Hematological malignancies in children with primary immunodeficiency

Authors

  • Svetlana SCIUCA IP USMF „Nicolae Testemițanu“
  • Cristina TOMACINSCHII IP USMF "Nicolae Testemițanu"
  • Rodica SELEVESTRU IP USMF "Nicolae Testemițanu"

DOI:

https://doi.org/10.52692/1857-0011.2023.2-76.09

Keywords:

ataxia, telangiectasia, lymphoma, immunodeficiencies, malignancies

Abstract

Primary immunodeficiencies (PIDs) represent a heterogeneous group of congenital disorders, often associated with specific genetic mutations. They are characterized by a varied spectrum of clinical manifestations, malignant tumors being the second cause of death among patients with primary immunodeficiencies after infections. The article presents the clinical case of a 13-year-old patient with a history of severe ataxia, telangiectasias, frequent respiratory infections, and cervical and submandibular lymphadenopathy diagnosed with IDP Ataxia Telangiectasia based on ESID criteria. Against the background of IDP, he is also diagnosed with Non-Hodgkin’s lymphoma.

Author Biographies

Svetlana SCIUCA, IP USMF „Nicolae Testemițanu“

Corr. member of the Academy of Sciences of Moldova, prof. at the univ., Ph.D. in med. sci.

Cristina TOMACINSCHII , IP USMF "Nicolae Testemițanu"

Ph.D. candidate, pediatrician

Rodica SELEVESTRU, IP USMF "Nicolae Testemițanu"

conf. univ., dr. St. med.

References

Abolhassani H., Wang Y., Hammarstrom L., Pan-Hammarstrom Q. Hallmarks of cancers: primary antibody deficiency versus other inborn errors of immunity. Front Immunol. 2021;12: 720025

Bomken S., van der Werff Ten Bosch J., et al. Current understanding and future research priorities in malignancy associated with inborn errors of immunity and DNA repair disorders: the perspective of an Interdisciplinary Working Group. Front Immunol. 2018;9:2912

Bousfiha A., Jeddane L., Picard C., et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1):66–81.

Filipovich A., Mathur A., Kamat D., et al.. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency. 1994;5(2):91–112.,

Haas O.A. Primary immunodeficiency and cancer predisposition revisited: embedding two closely related concepts into an integrative conceptual framework. Front Immunol. 2018;9:3136

Mayor P.C., Eng K.H., Singel K.L., et al. Cancer in Primary Immunodeficiency Diseases: Cancer Incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol (2018) 141(3):1028–35.

McCusker C., Upton J., Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):61

Picard C., Bobby Gaspar H., Al-Herz W., et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96–128.

Raje N., Dinakar C. Overview of immunodeficiency disorders. Immunol Allergy Clin North Am. 2015;35:599–623.

Sandoval C., Swift M. Hodgkin disease in ataxia‐telangiectasia patients with poor outcomes. Medical and Pediatric Oncology: The Official Journal of SIOP—International Society of Pediatric Oncology (Societé Internationale d’Oncologie Pédiatrique, 2003, 40.3: 162-166

Tiri A., Masetti R., Conti F., et al. Inborn errors of immunity and cancer. Biology (Basel). 2021;10(4):313

Tomacinschii C., et al. ABCL-311: The Burden of Non-Hodgkin Lymphoma Developed in an Ataxia Telangiectasia Child. Clinical Lymphoma Myeloma and Leukemia. 2020, 20: S272-S273.

Tomacinschii C., et al. Non-Hodgkin Lymphoma Developed in yhe clinical curs of a child with Wiskott Aldrich syndrome. Clinical lymphoma myeloma and leukemia. 2021, Vol. 20. P. 97. S395.

Published

2023-11-24

Issue

Section

Research Article

Categories